Since 2021, studies have integrated ITSS with relative cerebral blood volume (rCBV) to predict tumor grade in IDH-mutant astrocytomas, demonstrating significant outcomes with satisfactory results [5,12]. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).